CIK 0001520262
- Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981007018
- Phone
- +353 17728000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- 4 Open-market buy Director bought 10,000 shares at $26.43 ($264,269)
- 4 Open-market sale SVP, CLO, Alkermes, Inc. sold 14,000 shares at $26.00 ($364,000)
- 4 Open-market sale Director sold 20,000 shares at $24.58 ($491,504)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale SVP, CLO, Alkermes, Inc. sold 13,500 shares at $25.00 ($337,500)
- 4 Open-market sale Director sold 25,000 shares at $25.00 ($625,000)
- 4 Open-market sale EVP R&D, Chief Medical Officer sold 882 shares at $24.60 ($21,697)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes EVP R&D, Chief Medical Officer gave up 368 shares (to pay taxes)
- 4 Open-market sale SVP, CLO, Alkermes, Inc. sold 13,500 shares at $24.00 ($324,000)
- 4 Open-market sale Director sold 5,000 shares at $24.00 ($120,000)
Page 16 of 67 · 1,323 filings